siRNA treatment lowers triglycerides in patients with rare ailment
.RESEARCH STUDY HIGHLIGHT.19 September 2024.
Plozasiran minimized triglyceride levels through 80% and also decreased the danger of pancreatitis in people along with persistent chylomicronemia, with or without a genetic medical diagnosis.